DUBLIN--(BUSINESS WIRE)--The "Interventional Cardiology Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.
The global interventional cardiology devices market reached a value of US$ 19.58 Billion in 2021. Looking forward, the publisher expects the market to reach a value of US$ 32.21 Billion by 2027, exhibiting a CAGR of 8.65% during 2021-2027.
Companies Mentioned
- Abbott Laboratories
- Alvimedica
- B. Braun Melsungen AG
- Biosensors International Group Ltd. (Bluesail Medical Co. Ltd.)
- BIOTRONIK Inc.
- Boston Scientific Corporation
- Cook Group Incorporated
- ENDOCOR GmbH
- Koninklijke Philips N.V.
- Medinol Ltd.
- Medtronic plc
- Terumo Corporation
Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Interventional cardiology devices refer to the medical equipment and guiding tools used for performing cardiovascular procedures, such as angioplasty and stenting. Some of the commonly used devices include angioplasty balloons, stents, mitral, pulmonary and tricuspid valves, catheters, plaque modification and hemodynamic flow alteration devices. Along with this, guidewires, vascular closure and hemostasis devices and introducer sheaths are also utilized.
These tools and devices are widely used for medical procedures, such as coronary artery bypass grafting (CABG), trans-myocardial laser revascularization (TMR), arrhythmia treatment, aneurysm repair, open-heart, off-pump heart and minimally invasive (MI) heart surgeries. They are also used for other procedures, such as atherectomy, embolic protection and percutaneous valve repair.
The increasing prevalence of diabetes, hypertension and cardiovascular disorders, such as coronary artery disease (CAD, is one of the key factors driving the growth of the market. Moreover, the rising geriatric population, which is more susceptible to such ailments, is providing a thrust to the market growth. Interventional cardiology and embolic protection devices are widely used to capture embolic debris to ensure continuous blood flow and preventing blockages.
Additionally, the development of innovative bioabsorbable and drug-eluting stents, pacemakers and drug-coated mesh tubes is acting as another growth-inducing factor. In line with this, the increasing utilization of advanced imaging solutions, such as intravenous ultrasound (IVUS), fractional flow reserve (FFR) and optical coherence tomography (OCT) for early diagnosis and timely treatment of cardiovascular ailments, is also contributing to the growth of the market.
Other factors, including rising healthcare expenditure capacities of the masses, along with extensive improvements in the medical infrastructure, especially in the developing economies, are anticipated to drive the market toward growth.
Key Market Segmentation:
The publisher provides an analysis of the key trends in each sub-segment of the global interventional cardiology devices market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product and end user.
Breakup by Product:
- Stents
- Drug Eluting Stents
- Bare Metal Stents
- Bio-Absorbable Stents
- Interventional Catheters
- IVUS Catheters
- Guiding Catheters
- Angiography Catheters
- PTCA Guidewires
- Balloon Inflation Device
- PTCA Balloons
- Cutting Balloons
- Scoring Balloons
- Drug Eluting Balloons
- Normal Balloons
Breakup by End User:
- Hospitals
- Ambulatory Surgical Centers
- Others
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Key Questions Answered in This Report:
- How has the global interventional cardiology devices market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global interventional cardiology devices market?
- What are the key regional markets?
- What is the breakup of the market based on the product?
- What is the breakup of the market based on the end user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global interventional cardiology devices market and who are the key players?
- What is the degree of competition in the industry?
For more information about this report visit https://www.researchandmarkets.com/r/8ot16v
